The effect of plerixafor on autologous stem cell mobilization, cell viability, and apheresis challenges
Plerixafor is effective across multiple diagnoses using an oncologist-driven HSC collection endpoint. Its association with mobilization failure is likely attributable to its use in patients predicted to be poor mobilizers.
Authors
- Alexa J. Siddon (ORCID: https://orcid.org/0000-0002-2372-3653)
- Philippa Li (ORCID: https://orcid.org/0000-0003-4784-1977)
- Christopher A. Tormey (ORCID: https://orcid.org/0000-0003-1785-2245)
- Christian J Puzo
Institutions
- Yale University (US)
Publication Details
- Journal
- Laboratory Medicine
- Published
- 2024-09-20
- DOI
- https://doi.org/10.1093/labmed/lmae080
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00